Large Evaluation of Anti-Cardiolipin and anti-尾2 Glycoprotein I Assays: Results from the Autoimmunity Workshop of the Spanish Society of Immunology

详细信息	查看全文 | 推荐本文 |

• 作者：Marcos Ló ; pez-Hoyos¹ ; ^{inmlhm@humv.es} ; Dora Pascual-Salcedo² ; Lourdes Mozo³ ; Maria Rosa Juliá ; ⁴ ; Margarita Rodrí ; guez-Mahou⁵ ; Delia Almeida⁶ ; Montserrat Alsina⁷ ; Maria Luisa Vargas⁸ ; Julia Sequí ; ⁹ ; Raquel Sá ; ez¹⁰ ; Maria José ; Rodrigo¹¹ ; Á ; ngela Carrasco¹² ; Pilar Palomino¹³ ; Jordi Bas¹⁴ ; Aresio Plaza¹⁵ ; Yvelise Barrios¹⁶ ; Alvaro Prada¹⁷ ; Rosa Castro¹⁸ ; Rosa Maria Pastor¹⁹ ; José ; Marcos Garcí ; a-Pacheco²⁰ ; Luis Ferná ; ndez-Pereira²¹ ; Alfonso Sá ; nchez-Ibarrola²² ; Carmen Rodrí ; guez²³ ; Mercedes Nocito²⁴ ; Maria José ; Amengual²⁵ ; Inmaculada Alarcó ; n²⁶ ; Maria Á ; ngeles Figueredo²⁷ ; Laura Jaí ; mez²⁸ ; Juana Jimé ; nez²⁹ ; Antonio Serrano³⁰ ; Esther Ocañ ; a³¹ ; Eva Martí ; nez-Cá ; ceres³² ; Manuel Santamarí ; a³³ ; Neifred Villegas¹
• 关键词：Antiphospholipid Syndrome ; APL ; Anti-phospholipid antibodies ; Lupus anticoagulant ; Anti-cardiolipin antibodies ; Anti-尾2- glycoprotein I antibodies
• 刊名：Inmunolog铆a
• 出版年：2009
• 期刊代码：pca191_02139626
• 类别：med
• 出版时间：April-June 2009
• 卷：28
• 期：2
• 页码：74-78
• 文件大小：246 K

摘要

Despite their clinical utility and the importance that laboratory tests have in APS diagnosis, probably the most important drawback of such tests is the elevated intra- and inter-laboratory variation. The aim of the present work was to assess the multilaboratory performance of aCL and anti-尾 the multilaboratory performance of anti-cardiolipin (aCL) and antibeta 2 glycoprotein I antibodies (anti-尾2GPI) assays and to assess the interlaboratory and inter-assay variability. Here, we report the most significant results from the Autoimmunity Workshop of the Spanish Society of Immunology (AWSEI). Seventeen sera from patients with antiphospholipid syndrome (APS) and/or probable APS were collected after written informed consent. Thirty-three laboratories participated and measured aCL and anti-anti-尾2GPI. 61 and 49 results/serum for IgG/IgM aCL and anti- anti-尾2GPI, respectively, were informed with 20 different assays. A high interlaboratory variation was found in quantitative results regardless the method used. Coefficient of variation ranged from 50%to 128%for aCL and from 9%to 200%for anti-anti-尾2GPI. A limited consensus (defined as >90%agreement) was observed in semiquantitative results for IgG/IgM aCL and anti-尾2GPI: 47%, 65%, 47%and 70%, respectively. In general, there was concordance between aCL and anti-尾2GPI, yet 2 of the 17 sera were positive for anti-尾2GPI only. In conclusion, interpretation of aCL and anti-尾2GPI results from different laboratories may be done only in semiquantitative terms and its real value for clinical diagnosis of APS is still limited. Cut off values must be set in each laboratory.